BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Pharm Country

  Bayer HealthCare Release: Betaseron(R) to Offer the Thinnest Needle in Multiple Sclerosis

  September 15, 2008

   · 

  1 min read
• Drug Development

  NPS Pharmaceuticals, Inc. Announces Positive Interim Data from Phase 2 Study of NPSP558

  September 15, 2008

   · 

  8 min read
• Pharm Country

  Delisting of Securities of Genitope Corporation From the NASDAQ Stock Market

  September 15, 2008

   · 

  1 min read
• Drug Development

  Bayer HealthCare’s Betaseron(R) to Offer the Thinnest Needle in Multiple Sclerosis

  September 15, 2008

   · 

  7 min read
• MIV Therapeutics Inc. VESTAsync™ Drug-Eluting Stent Trials Progress

  September 15, 2008

   · 

  1 min read
• Drug Development

  Enanta Pharmaceuticals, Inc. Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital

  September 15, 2008

   · 

  3 min read
• Business

  Algenol Biofuels Further Strengthens Team With Key Appointments

  September 15, 2008

   · 

  2 min read
• Novo Nordisk A/S -- Transaction in Own Shares

  September 15, 2008

   · 

  1 min read
• Pharm Country

  Pluristem Therapeutics to Present at the bioLOGIC Conference

  September 15, 2008

   · 

  1 min read
• Policy

  Teva Pharmaceutical Industries Limited Announces Appellate Court Reverses Generic Risperdal(R) Exclusivity Decision

  September 15, 2008

   · 

  1 min read